Biblio

Export 3145 results:
[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
E. van den Berg, Nilsson, J., Kersten, I., Brinkmalm, G., de Kort, A. M., Klijn, C. J. M., Schreuder, F. H. B. M., Jäkel, L., Gobom, J., Portelius, E., Zetterberg, H., Brinkmalm, A., Blennow, K., H Kuiperij, B., and Verbeek, M. M., “Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 2, pp. 467-475, 2023.
I. E. van de Vorst, Koek, H. L., Bots, M. L., and Vaartjes, I., “Evaluation of Underlying Causes of Death in Patients with Dementia to Support Targeted Advance Care Planning.”, J Alzheimers Dis, vol. 53, no. 1, pp. 117-25, 2016.
C. Pieternell van Buuren, van der Steen, J. Theodora, Olthof-Nefkens, M., Bakker, C., Koopmans, R. Theodorus, Perry, M., and Kalf, J. Gezina, “The Complexity of Nutritional Problems in Persons with Dementia: Expanding a Theoretical Model.”, J Alzheimers Dis, vol. 96, no. 1, pp. 183-192, 2023.
J. Vallortigara, Whitfield, D., Quelch, W., Alghamdi, A., Howlett, D., Hortobágyi, T., Johnson, M., Attems, J., O'Brien, J. T., Thomas, A., Ballard, C. G., Aarsland, D., and Francis, P. T., “Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia.”, J Alzheimers Dis, vol. 50, no. 1, pp. 101-10, 2016.
R. Valenti, Charidimou, A., Xiong, L., Boulouis, G., Fotiadis, P., Ayres, A., Riley, G., Kuijf, H. J., Reijmer, Y. D., Pantoni, L., M Gurol, E., Davidsdottir, S., Greenberg, S. M., and Viswanathan, A., “Visuospatial Functioning in Cerebral Amyloid Angiopathy: A Pilot Study.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1223-1227, 2017.
N. Valech, Tort-Merino, A., Coll-Padrós, N., Olives, J., León, M., Rami, L., and Molinuevo, J. Luis, “Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.”, J Alzheimers Dis, vol. 61, no. 2, pp. 689-703, 2018.
V. Valdiglesias, Maseda, A., Lorenzo-López, L., Pásaro, E., Millán-Calenti, J. C., and Laffon, B., “Is Salivary Chromogranin A a Valid Psychological Stress Biomarker During Sensory Stimulation in People with Advanced Dementia?”, J Alzheimers Dis, vol. 55, no. 4, pp. 1509-1517, 2017.
C. Vakalopoulos, “Alzheimer's Disease: The Alternative Serotonergic Hypothesis of Cognitive Decline.”, J Alzheimers Dis, vol. 60, no. 3, pp. 859-866, 2017.
U
M. Ułamek-Kozioł, Kocki, J., Bogucka-Kocka, A., Petniak, A., Gil-Kulik, P., Januszewski, S., Bogucki, J., Jabłoński, M., Furmaga-Jabłońska, W., Brzozowska, J., Czuczwar, S. J., and Pluta, R., “Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 113-21, 2016.
B. Soukupova Urbanova, Schwabova, J. Paulasova, Magerova, H., Jansky, P., Marková, H., Vyhnálek, M., Laczó, J., Hort, J., and Tomek, A., “Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 63, no. 2, pp. 465-477, 2018.
I. Ulstein and Bøhmer, T., “Normal Vitamin Levels and Nutritional Indices in Alzheimer's Disease Patients with Mild Cognitive Impairment or Dementia with Normal Body Mass Indexes.”, J Alzheimers Dis, vol. 55, no. 2, pp. 717-725, 2017.
S. Ukraintseva, Duan, H., Holmes, R., Bagley, O., Wu, D., Yashkin, A., Kulminski, A., Akushevich, I., Whitson, H., Stallard, E., Yashin, A., and Arbeev, K., “Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 1, pp. 163-170, 2023.
I. L. Uijen, Aaronson, J. A., Karssemeijer, E. G. A., Rikkert, M. G. M. Olde, and Kessels, R. P. C., “Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia.”, J Alzheimers Dis, vol. 74, no. 2, pp. 435-439, 2020.
K. Uekawa, Hasegawa, Y., Senju, S., Nakagata, N., Ma, M., Nakagawa, T., Koibuchi, N., and Kim-Mitsuyama, S., “Intracerebroventricular Infusion of Angiotensin-(1-7) Ameliorates Cognitive Impairment and Memory Dysfunction in a Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 127-33, 2016.
Y. Ueda, Satoh, M., Tabei, K. - I., Kida, H., Ii, Y., Asahi, M., Maeda, M., Sakuma, H., and Tomimoto, H., “Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging.”, J Alzheimers Dis, vol. 53, no. 1, pp. 315-25, 2016.
T
M. A. Tyumentsev, Stefanova, N. A., Muraleva, N. A., Rumyantseva, Y. V., Kiseleva, E., Vavilin, V. A., and Kolosova, N. G., “Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1075-1088, 2018.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
M. Tuwaig, Savard, M., Jutras, B., Poirier, J., D Collins, L., Rosa-Neto, P., Fontaine, D., and Breitner, J. C. S., “Deficit in Central Auditory Processing as a Biomarker of Pre-Clinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1589-1600, 2017.
O. Turró-Garriga, Garre-Olmo, J., Reñé-Ramírez, R., Calvó-Perxas, L., Gascón-Bayarri, J., and Conde-Sala, J. - L., “Consequences of Anosognosia on the Cost of Caregivers' Care in Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1551-1560, 2016.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, “Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up.”, J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
O. Turró-Garriga, Calvó-Perxas, L., Vilalta-Franch, J., Hernández-Ferrándiz, M., Flaqué, M., Linares, M., Cullell, M., Gich, J., Casas, I., Perkal, H., and Garre-Olmo, J., “Adherence to Clinical Practice Guidelines during Dementia Work-Up in a Real-World Setting: A Study from the Registry of Dementias of Girona.”, J Alzheimers Dis, vol. 59, no. 3, pp. 997-1007, 2017.
M. T. Turnbull and Coulson, E. J., “Cholinergic Basal Forebrain Lesion Decreases Neurotrophin Signaling without Affecting Tau Hyperphosphorylation in Genetically Susceptible Mice.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1141-1154, 2017.
C. Stella Turchetta, Perri, R., Fadda, L., Caruso, G., De Simone, M. Stefania, Caltagirone, C., and Carlesimo, G. Augusto, “Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi.”, J Alzheimers Dis, vol. 66, no. 2, pp. 461-470, 2018.
G. Tuna, Yener, G. Gülmen, Oktay, G., İşlekel, G. Hüray, and Kİrkalİ, F. Güldal, “Evaluation of Matrix Metalloproteinase-2 (MMP-2) and -9 (MMP-9) and Their Tissue Inhibitors (TIMP-1 and TIMP-2) in Plasma from Patients with Neurodegenerative Dementia.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1265-1273, 2018.
G. Tumminelli, Di Donato, I., Guida, V., Rufa, A., De Luca, A., and Federico, A., “Oculodentodigital dysplasia with massive brain calcification and a new mutation of GJA1 gene.”, J Alzheimers Dis, vol. 49, no. 1, pp. 27-30, 2016.

Pages